Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Current Assets (2016 - 2026)

SANUWAVE Health has reported Current Assets over the past 17 years, most recently at $24.0 million for Q1 2026.

  • Quarterly Current Assets rose 27.22% to $24.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Mar 2026, up 27.22% year-over-year, with the annual reading at $24.6 million for FY2025, 33.86% up from the prior year.
  • Current Assets was $24.0 million for Q1 2026 at SANUWAVE Health, down from $24.6 million in the prior quarter.
  • Over five years, Current Assets peaked at $24.6 million in Q4 2025 and troughed at $3.4 million in Q1 2022.
  • The 5-year median for Current Assets is $9.8 million (2023), against an average of $12.1 million.
  • Year-over-year, Current Assets plummeted 33.97% in 2022 and then skyrocketed 139.78% in 2024.
  • A 5-year view of Current Assets shows it stood at $6.6 million in 2022, then surged by 47.79% to $9.8 million in 2023, then skyrocketed by 88.03% to $18.4 million in 2024, then surged by 33.86% to $24.6 million in 2025, then decreased by 2.72% to $24.0 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Current Assets are $24.0 million (Q1 2026), $24.6 million (Q4 2025), and $22.6 million (Q3 2025).